Baird Medical Investment Holdings Limited
BDMD
$1.95
$0.052.63%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -39.41% | -39.41% | 20.03% | 20.03% | 13.77% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -39.41% | -39.41% | 20.03% | 20.03% | 13.77% |
| Cost of Revenue | -13.45% | -13.45% | 25.33% | 25.33% | -19.45% |
| Gross Profit | -43.13% | -43.13% | 19.38% | 19.38% | 20.92% |
| SG&A Expenses | 124.15% | 124.15% | -1.17% | -1.17% | 3.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 128.77% | 128.77% | 23.83% | 23.83% | -5.91% |
| Operating Income | -305.34% | -305.34% | 15.31% | 15.31% | 70.01% |
| Income Before Tax | -319.70% | -319.70% | -2.03% | -2.03% | 65.35% |
| Income Tax Expenses | 16.21% | 16.21% | -9.92% | -9.92% | -17.32% |
| Earnings from Continuing Operations | -356.64% | -356.64% | -0.97% | -0.97% | 85.78% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -45.54% | -45.54% | -13.93% | -13.93% | -82.11% |
| Net Income | -360.81% | -360.81% | -1.12% | -1.12% | 85.81% |
| EBIT | -305.34% | -305.34% | 15.31% | 15.31% | 70.01% |
| EBITDA | -273.40% | -273.40% | 13.75% | 13.75% | 66.83% |
| EPS Basic | -352.54% | -352.54% | -1.11% | -1.11% | 113.89% |
| Normalized Basic EPS | -317.95% | -317.95% | -2.32% | -2.32% | 89.94% |
| EPS Diluted | -353.84% | -353.84% | -0.27% | -0.27% | 113.89% |
| Normalized Diluted EPS | -317.95% | -317.95% | -2.92% | -2.92% | 89.94% |
| Average Basic Shares Outstanding | 3.32% | 3.32% | 0.00% | 0.00% | -13.11% |
| Average Diluted Shares Outstanding | 3.32% | 3.32% | 0.67% | 0.67% | -13.11% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |